Microbubbles have been the earliest and most widely used ultrasound contrast agents by
virtue of their unique features: such as non-toxicity, intravenous injectability, ability to cross …

The design of emulsions containing systems able to respond to different kinds of
perturbations is attracting increasing interest for biomedical purposes. Emulsions of phase …

Objective. Protoacoustic imaging showed great promise in providing real-time 3D dose
verification of proton therapy. However, the limited acquisition angle in protoacoustic …

Abstract p-boronophenylalanine (BPA) is so far the most promising drug in clinical boron
neutron capture therapy (BNCT) due to its safety and selective targeting of numerous cancer …

Purpose The purpose of this phantom study is to demonstrate that thermoacoustic range
verification could be performed clinically. Thermoacoustic emissions generated in an …

The potential of proton therapy to improve the conformity of the delivered dose to the tumor
volume is currently limited by range uncertainties. Injectable superheated nanodroplets …

Objective. Proton therapy as the next generation radiation-based cancer therapy offers
dominant advantages over conventional radiation therapy due to the utilization of the Bragg …

Over the last two decades, liquid perfluorocarbon nanodroplets (PFC-NDs), also known as
Phase Change Contrast Agents (PCCAs), that are capable of vaporizing into gaseous …

Purpose Despite the physical benefits of protons over conventional photon radiation in
cancer treatment, range uncertainties impede the ability to harness the full potential of …

Featured Application Multi-channel ultrasound platform for research in volumetric imaging
with matrix arrays. Abstract Volumetric ultrasound imaging is of great importance in many …